Literature DB >> 8690780

Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

J Gaschet1, A Lim, L Liem, R Vivien, M M Hallet, J L Harousseau, J Even, E Goulmy, M Bonneville, N Milpied, H Vié.   

Abstract

Analysis of a large number of unrelated bone marrow transplantations (BMT) has shown that HLA-DP incompatibility did not detectably influence the risk for acute graft-versus-host disease (aGVHD). Accordingly, it was proposed that HLA-DP determinants did not function as transplantation antigens in the same way as HLA-A, -B, or -DR. We have previously shown that HLA-DP (as well as HLA-A, -B, -DQ, or -DR)-specific T cells could be isolated from skin biopsies of patients who developed an aGVHD after semiallogeneic BMT. Nevertheless, whether a single HLA-DP mismatched allele could induce a detectable allo-specific reaction in vivo after BMT remained to be established. To directly address this issue we studied one patient who presented aGVHD after receiving purified CD34+ bone marrow (BM) cells from an unrelated donor with a single HLA-DP mismatch in the GVHD direction. To characterize the immunological events associated with GVHD, we analyzed the peripheral T cell repertoire, the T cell receptor Vbeta diversity, and the specificity of T cells invading a skin biopsy at the onset of GVHD. Our results demonstrated that a large fraction of skin-infiltrating lymphocytes, which expressed diverse T cell receptors, were reactive against this single HLA-DPB1 *0501 mismatch and consequently that a single HLA-DP mismatch between BM donor and recipient can activate a strong T cell response in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690780      PMCID: PMC507405          DOI: 10.1172/JCI118753

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Quantitative titration of nucleic acids by enzymatic amplification reactions run to saturation.

Authors:  C Pannetier; S Delassus; S Darche; C Saucier; P Kourilsky
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

2.  Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.

Authors:  P G Beatty; C Anasetti; J A Hansen; G M Longton; J E Sanders; P J Martin; E M Mickelson; S Y Choo; E W Petersdorf; M S Pepe
Journal:  Blood       Date:  1993-01-01       Impact factor: 22.113

3.  The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments.

Authors:  C Pannetier; M Cochet; S Darche; A Casrouge; M Zöller; P Kourilsky
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

4.  The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation.

Authors:  E W Petersdorf; A G Smith; E M Mickelson; G M Longton; C Anasetti; S Y Choo; P J Martin; J A Hansen
Journal:  Blood       Date:  1993-04-01       Impact factor: 22.113

5.  Ganciclovir treatment of herpes simplex thymidine kinase-transduced primary T lymphocytes: an approach for specific in vivo donor T-cell depletion after bone marrow transplantation?

Authors:  P Tiberghien; C W Reynolds; J Keller; S Spence; M Deschaseaux; J M Certoux; E Contassot; W J Murphy; R Lyons; Y Chiang
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

6.  Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease.

Authors:  P Y Dietrich; A Caignard; A Diu; C Genevee; J L Pico; M Henry-Amar; J Bosq; E Angevin; F Triebel; T Hercend
Journal:  Blood       Date:  1992-11-01       Impact factor: 22.113

7.  In vivo T-cell clonal amplification at time of acute graft-versus-host disease.

Authors:  P Y Dietrich; A Caignard; A Lim; V Chung; J L Pico; C Pannetier; P Kourilsky; T Hercend; J Even; F Triebel
Journal:  Blood       Date:  1994-10-15       Impact factor: 22.113

8.  Specificity of T cells invading the skin during acute graft-vs.-host disease after semiallogeneic bone marrow transplantation.

Authors:  J Gaschet; B Mahé; N Milpied; M C Devilder; B Dréno; J D Bignon; F Davodeau; M M Hallet; M Bonneville; H Vié
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  HLA-target antigens and T-cell receptor diversity of activated T cells invading the skin during acute graft-versus-host disease.

Authors:  J Gaschet; M A Treviño; M Cherel; R Vivien; A Garcia-Sahuquillo; M M Hallet; M Bonneville; J L Harrousseau; R Bragado; N Milpied; H Vié
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

10.  Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.

Authors:  P G Beatty; J A Hansen; G M Longton; E D Thomas; J E Sanders; P J Martin; S I Bearman; C Anasetti; E W Petersdorf; E M Mickelson
Journal:  Transplantation       Date:  1991-02       Impact factor: 4.939

View more
  7 in total

1.  Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study.

Authors:  K Gagne; P Loiseau; V Dubois; F Dufossé; P Perrier; A Dormoy; I Jollet; V Renac; D Masson; C Picard; X Lafarge; D Hanau; F Quainon; F Delbos; B Coeffic; Léna Absi; J-F Eliaou; V Moalic; M Fort; M de Matteis; I Theodorou; F Hau; A Batho; B Pedron; S Caillat-Zucman; E Marry; N Raus; I Yakoub-Agha; A Cesbron
Journal:  Bone Marrow Transplant       Date:  2014-11-03       Impact factor: 5.483

2.  Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

Authors:  E J Claret; E P Alyea; E Orsini; C C Pickett; H Collins; Y Wang; D Neuberg; R J Soiffer; J Ritz
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

Authors:  Katharina Fleischhauer; Bronwen E Shaw; Theodore Gooley; Mari Malkki; Peter Bardy; Jean-Denis Bignon; Valérie Dubois; Mary M Horowitz; J Alejandro Madrigal; Yasuo Morishima; Machteld Oudshoorn; Olle Ringden; Stephen Spellman; Andrea Velardi; Elisabetta Zino; Effie W Petersdorf
Journal:  Lancet Oncol       Date:  2012-02-15       Impact factor: 41.316

Review 4.  Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT.

Authors:  Edus H Warren; Xinyi Cindy Zhang; Shuying Li; Wenhong Fan; Barry E Storer; Jason W Chien; Michael J Boeckh; Lue Ping Zhao; Paul J Martin; John A Hansen
Journal:  Blood       Date:  2012-08-02       Impact factor: 22.113

5.  Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein.

Authors:  Zhitao Ru; Wenjun Xiao; Anthony Pajot; Zhihua Kou; Shihui Sun; Bernard Maillere; Guangyu Zhao; David M Ojcius; Yu-Chun Lone; Yusen Zhou
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

6.  Revisit of Optimal Donor Number Estimation in the Hong Kong Bone Marrow Donor Registry.

Authors:  Jenny Chung Yee Ho; Stephen Kwok Fan Cheung; Zhongyi Lui; Ivan Wing Hong Tang; Wanling Yang; Patrick Ip; Cheuk Kwong Lee; Derek Middleton; Janette Siu Yin Kwok
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

7.  GMP-Grade Manufacturing of T Cells Engineered to Express a Defined γδTCR.

Authors:  Trudy Straetemans; Guido J J Kierkels; Ruud Doorn; Koen Jansen; Sabine Heijhuurs; Joao M Dos Santos; Anna D D van Muyden; Henri Vie; Béatrice Clemenceau; Reinier Raymakers; Moniek de Witte; Zsolt Sebestyén; Jürgen Kuball
Journal:  Front Immunol       Date:  2018-05-30       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.